RedHill Biopharma (RDHL) Tops Q3 EPS by 16c

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/22/2026

1. SPCX
2. NVDA
3. NFLX
4. META
5. TSLA
6. ISRG
7. SMCI
8. RTX
9. GOOGL
10. S

Go back to RedHill Biopharma (RDHL) Tops Q3 EPS by 16c

RedHill Biopharma Reports Operational Highlights and Third Quarter 2021 Financial Results

November 30, 2021 7:00 AM EST

RedHill Accelerates its Two Advanced COVID-19 Pill Clinical Programs in Light of their Potential Against Omicron

Acting independently of spike protein mutation, opaganib and RHB-107's unique host-targeted mechanisms of action hold potential versus Omicron and other variants

-- Phase 2/3 study sub-population analysis demonstrated a 62% reduction in mortality in moderately severe hospitalized patients; Data packages submitted in the U.S., EU (EMA has provided expedited evaluation process timelines), UK and other territories, ahead of regulatory advice

-- Top-line data from Part A of the COVID-19 Phase 2/3 study of RHB-107 (upamostat)... More